心血管药物和治疗(Cardiovascular Drugs And Therapy)是一本由Springer US出版的一本医学-心血管系统学术刊物,主要报道医学-心血管系统相关领域研究成果与实践。本刊已入选来源期刊,该刊创刊于1987年,出版周期Bimonthly。2021-2022年最新版WOS分区等级:Q2,2023年发布的影响因子为3.1,CiteScore指数8.3,SJR指数0.973。本刊...
Cardiovascular Drugs and Therapy《心血管药物与治疗》 (官网投稿) 简介 期刊简称CARDIOVASC DRUG THER 参考译名《心血管药物与治疗》 核心类别 SCIE(2024版), 目次收录(维普), 知网外文库,外文期刊, IF影响因子 自引率2.80% 主要研究方向医学-CARDIAC & CARDIOVASCULAR SYSTEMS心脏和心血管系统;PHARMACOLOGY & ...
《CARDIOVASCULAR DRUGS AND THERAPY》 期刊名缩写:CARDIOVASC DRUG THER 22年影响因子:3.947 issn:0920-3206 eIssn:1573-7241 类别:医学 学科与分区:药理学和药理学(PHARMACOLOGY & PHARMACY) - SCIE(Q2)心脏和心血管系统(CARDIAC & CARDIOVASCULAR SYSTEMS) - SCIE(Q2)...
Cardiovascular Drugs and Therapy该刊的官方投稿网址为: editorialmanager.com/cd 自引率 期刊Cardiovascular Drugs and Therapy自引率为0 影响因子 期刊Cardiovascular Drugs and Therapy,最新影响因子为3.4,近年发展较稳定。 后台扫描,可以查看更多期刊信息 审稿周期 从Cardiovascular Drugs and Therapy官网数据显示来看,...
Cardiovascular Drugs And Therapy位于中科院3区,其最新影响因子3.947,自引率处于安全范围内,其发文量近两年连续增加,另外在2019-2021年度国人发文量位列第三,国人友好,对该期刊感兴趣的小伙伴可以了解一下。 时间急,投稿总被拒? 扫码咨询,最快2-4个月录用 ...
Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic ...
网络心血管药物与治疗;期刊全名 网络释义
期刊名称:《Cardiovascular drugs and therapy》 | 2022年第2期 关键词: Atherosclerosis; Canakinumab; Clonal hematopoiesis; Colchicine; Epicardial adipose tissue; Inflammation; C-REACTIVE PROTEIN; INNATE LYMPHOID-CELLS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; EPICARDIAL ADIPOSE-TISSUE; INTERLEUKIN-1 INDUCES INTER...
Cardiovascular Drugs and Therapy focuses on developments in treatment of hyperlipidemia, diabetes and other cardiometabolic conditions, atherosclerosis, ischemic syndromes, heart failure, cardiomyopathies, valvular heart disease, and arrhythmias. These include mechanisms of action and signaling pathways, their...